03:53 AM EDT, 09/02/2025 (MT Newswires) -- Zai Lab ( ZLAB ) said late Monday that the Hong Kong Department of Health has approved Tivdak for the treatment of adults with recurrent or metastatic cervical cancer.
The drug is currently under regulatory review in China, the company said.